US Broker Ratings

Insulet Corporation (PODD) Stock Analysis: Exploring a 21.77% Potential Upside in the Healthcare Sector

Insulet Corporation (NASDAQ: PODD) continues to capture the attention of investors seeking opportunities within the healthcare sector, particularly in the burgeoning field of medical devices. With..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 9.14% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, offers a compelling investment opportunity with a potential upside of 9.14% based on current..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Strong Buy Ratings and Potential for Growth in Healthcare

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector with a market cap of $219.63 billion, continues to attract investors’ attention. As a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Healthcare Innovator with a 12.53% Upside Potential

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, continues to captivate investor attention with its robust market presence and promising growth..

Quest Diagnostics (DGX) Stock Analysis: Exploring the Growth Potential in Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare diagnostics and research industry, offers a compelling investment thesis for those looking to capitalize on the..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Investor Outlook with a 15% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a global leader in clinical research services and healthcare intelligence, is capturing the attention of investors with its robust growth prospects..

Haleon plc (HLN) Investor Outlook: Exploring a 19.58% Potential Upside in the Healthcare Giant

Haleon plc (NYSE: HLN), a leader in the healthcare sector with a market capitalization of $44.17 billion, is capturing investor attention with its robust portfolio of..

Stryker Corporation (SYK) Stock Analysis: Healthcare Giant Set for 12.69% Upside Potential

Stryker Corporation (NYSE: SYK) stands out in the healthcare sector as a formidable player in the medical device industry, attracting considerable attention from investors. With a..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring Growth Potential in Oncology with a Strong ROE

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology sector, particularly within oncology, as a company committed to the discovery and development of treatments for challenging..

Amgen Inc. (AMGN) Stock Analysis: Navigating a Strong Market Cap with High Return on Equity

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to be a focal point for investors with its impressive market capitalization of $221.79 billion...

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 17% Potential Upside with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC) is capturing the attention of investors with its robust market position in the healthcare sector, specifically within the medical care facilities..

Eli Lilly (LLY) Stock Analysis: 9% Upside Potential Amid Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY) continues to capture the attention of investors, particularly with its impressive market capitalization of $1.06 trillion, placing it firmly among..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating a 11.48% Upside Potential Amid Healthcare Growth

As investors continue to explore opportunities in the healthcare sector, Universal Health Services, Inc. (NYSE: UHS) stands out with a compelling combination of growth potential and..

Cencora, Inc. (COR) Stock Analysis: Healthcare Distribution Giant with a 14.60% Upside Potential

Cencora, Inc. (COR), a stalwart in the healthcare sector specializing in medical distribution, presents an intriguing opportunity for investors seeking both stability and growth potential. With..

GSK plc (GSK) Stock Analysis: Exploring a 9.66% Potential Upside in the Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising outlook. As of the..

Boston Scientific Corporation (BSX) Stock Analysis: Is a 27% Upside on the Horizon?

Boston Scientific Corporation (NYSE: BSX), a leading player in the healthcare sector, particularly in the medical devices industry, has piqued investor interest with its robust market..

Novo Nordisk A/S (NVO) Stock Analysis: Navigating Growth and Stability with a 59.82% ROE

Novo Nordisk A/S (NVO), a titan in the healthcare sector, commands a formidable presence in the drug manufacturing industry with a market capitalization of $208.92 billion...

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating Growth in the Diagnostics & Research Sphere

Mettler-Toledo International, Inc. (NYSE: MTD) has established itself as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Greifensee,..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating a 12.30% Upside Potential in the Biotech Arena

Royalty Pharma plc (NASDAQ: RPRX) stands out in the healthcare sector, specifically within the biotechnology industry, as a unique player that capitalizes on biopharmaceutical royalties. This..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating Biotech Opportunities with a 6.27% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a heavyweight in the biotechnology sector, boasting a market cap of $80.75 billion. With its headquarters in Tarrytown, New York,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds